Why is Aarti Pharma falling/rising?

As of 11-Jul, Aarti Pharmalabs Ltd is experiencing a price increase, currently at Rs 923.00, reflecting a rise of Rs 10.55 or 1.16%. The stock has shown strong performance recently, gaining 2.44% over the past week and 0.54% over the past month, while it has outperformed the sector by 0.58% today. It is also trading close to its 52-week high, just 2.8% away from Rs 948.8. Despite a recent decline in investor participation, with delivery volume dropping by 49.32% against the 5-day average, the stock's fundamentals remain strong, highlighted by a low Debt to EBITDA ratio of 0.63 times and impressive growth in profit before tax and profit after tax, both increasing by 41.7% compared to the previous four-quarter average.
In the broader market context, Aarti Pharmalabs has significantly outperformed the benchmark, generating a return of 49.29% over the past year compared to the BSE500's return of only 0.52%. This strong performance is underpinned by attractive valuations and a solid return on capital employed of 16.1%. However, there are concerns regarding long-term growth, as net sales have only grown at an annual rate of 4.27% over the last five years, and institutional investor participation has decreased by 4.11% in the previous quarter, indicating potential caution among larger investors.